Northern Trust
TTNP

Northern Trust’s Titan Pharmaceuticals TTNP Stock Holding History

Northern Trust’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-321
Closed -$32K – 4418
2020
Q3 		$32K Hold
321
– – ﹤0.01% 4152
2020
Q2 		$59K Buy
321
+175
+120% +$30.1K ﹤0.01% 4029
2020
Q1 		$20K Buy
146
+121
+484% +$18.9K ﹤0.01% 4088
2019
Q4 		$3K Hold
25
– – ﹤0.01% 4241
2019
Q3 		$4K Hold
25
– – ﹤0.01% 4224
2019
Q2 		$19K Hold
25
– – ﹤0.01% 4175
2019
Q1 		$27K Buy
25
+11
+79% +$10.7K ﹤0.01% 4104
2018
Q4 		$11K Sell
14
-1
-7% -$1.12K ﹤0.01% 4195
2018
Q3 		$11K Hold
15
– – ﹤0.01% 4251
2018
Q2 		$57K Hold
15
– – ﹤0.01% 4107
2018
Q1 		$55K Hold
15
– – ﹤0.01% 4068
2017
Q4 		$71K Buy
15
+2
+15% +$12.4K ﹤0.01% 4033
2017
Q3 		$84K Hold
13
– – ﹤0.01% 3988
2017
Q2 		$92K Sell
13
-44
-77% -$409K ﹤0.01% 3991
2017
Q1 		$678K Buy
57
+3
+6% +$42.2K ﹤0.01% 3461
2016
Q4 		$781K Sell
54
-2
-4% -$33.7K ﹤0.01% 3416
2016
Q3 		$1.18M Buy
56
+3
+6% +$58.3K ﹤0.01% 3296
2016
Q2 		$1.05M Buy
53
+46
+657% +$980K ﹤0.01% 3331
2016
Q1 		$114K Buy
7
+3
+75% +$40K ﹤0.01% 3881
2015
Q4 		$69K Buy
+4
New +$65.2K ﹤0.01% 4004

Other funds holding TTNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TI
tru Independence Portland, Oregon $202M AUM 15.81% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Northern Trust's TTNP Position: Q4 2020 in Review

Northern Trust sold out of Titan Pharmaceuticals (TTNP) in Q4 2020, closing a stake of 321 shares — an estimated $32K sold.

Northern Trust first reported a position in TTNP in Q4 2015 and held it in 20 quarters. The position peaked at $1.18M in Q3 2016. 15 funds tracked by Wall St. Rank hold TTNP as of Q4 2020.

  • Northern Trust reported no remaining Titan Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Northern Trust sold 321 Titan Pharmaceuticals shares in Q4 2020, an estimated $32K.
  • Northern Trust first reported a position in Titan Pharmaceuticals in Q4 2015 and held it in 20 quarters.
  • Northern Trust's Titan Pharmaceuticals position peaked at $1.18M in Q3 2016.
  • 15 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2020.

Based on Northern Trust's 13F filing for Q4 2020, filed 11 Feb 2021.